China's health regulators are rolling out a corporate blacklist for drug and medical-device companies implicated in commercial bribery, a move aimed at stamping out corruption in the country's health-care sector.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303345104579284061219841096.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303345104579284061219841096.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento